Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI◊ Surgical System Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System from the United States Food and Drug Administration. The system is designed to address the evolving demands of primary hip surgery including the increased adoption of anterior approach procedures and the expanding role of Ambulatory Surg ...

Business: Smith & Nephew is a British portfolio medical technology company that operates worldwide. The company develops, manufactures, markets and sells medical devices and services. Its segments include Orthopedics, Sports Medicine and Ear, Nose and Throat, as well as Advanced Wound Management. Its Orthopedics segment includes a range of hip and knee implants to replace damaged or worn joints, robotics-assisted and digital enabling technologies, as well as trauma products used to stabilize severe fracture ...

Smith & Nephew SNATS (SNN) is likely to witness operational improvements in the future as Cevian Capital, a Swedish investment firm, purchased a 5% stake in the company. Per the Securities and Exchange Commission disclosure, Cevian Capital now has 5% of voting rights attached to the shares. This purchase makes the investment firm the second-largest shareholder of Smith & Nephew.Cevian Capital is known to collaborate with the boards and management teams of companies where it buys equity to promote plans that ...

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavours to help people live their ‘Life Unlimited' by aiding in their recovery from injury and get them back to doing what they love. Click to play video - Smith+Nephew Proud Player Sponsor at The Championships, Wimbled ...

Smith & Nephew SNATS (SNN) recently announced the launch of its new CORIOGRAPH Pre-Operative Planning and Modeling Services. This launch is likely to provide personalized solutions for surgeons and patients across partial and total knee arthroplasty procedures. CORIOGRAPGH is intended to be used exclusively with the CORI Surgical System, the only robotically assisted orthopedic system that allows surgeons to select whether to perform a preoperative MRI scan or not by providing intraoperative image-free or i ...

The Good Brigade/DigitalVision via Getty Images Medical devices and supplies manufacturer Smith & Nephew (NYSE:SNN) (OTCPK:SNNUF) has had an underwhelming several years, but at its core is a well- positioned business in a business area with premium pricing and long-term growth prospects. My last piece on the name was September 2022’s Smith & Nephew: Still A Buy Despite Short-Term Challenges, rating it a buy. Since then, the shares have increased in price by 14%. I continue to think that the share price unde ...

Smith & Nephew plc (NYSE:SNN) Q1 2024 Sales/Trading Statement Conference Call May 1, 2024 3:30 AM ET Company Participants Deepak Nath - Chief Executive Officer John Rogers - Chief Financial Officer Conference Call Participants Jack Reynolds-Clark - RBC Capital Markets Caitlin Cronin - Canaccord Genuity Hassan Al-Wakeel - Barclays Julien Dormois - Jefferies Veronika Dubajova - Citi Dylan Van Haaftan - Stifel David Adlington - JPMorgan Sezgi Ozener - HSBC Deepak Nath Good morning, and welcome to the Smith & N ...

First Quarter 2024 1 May 2024 Forward looking statements and non-IFRS measures This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forw ...

Exhibit 99.1 Life Unlimited Annual Report 2023 CRwEm1FtichREGgCGCR11DIGs1csNCNO2STammwirSoLperDUpm1mse+ociin m nnh n e e1u tat ha6 el 2 7 3r fihxr7ap4i hx n h moee iooei ooo i inoo raatn a f vvfa oe aanr d e p vos r t v4 ahl s p ase o a 1 2 5 o .re2eo ehg aenp t mmp tmt d eevv tto n lr sa erraK e 5k i r f nih ha u ee i geee r r dul t r.k t ggcu se ie a r vceeto o e ssD t Uvtc A s en en tpG O o %7h iaIe pp p e er r ss emmrhe r eu p e niig x it Fs ttgrr f fr a er rdue e 7nn su c e g %ne + tcio meny al al lhn ...

UNITED STATES SECURITIES ANDEXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F INFORMATION FOR SHAREHOLDERS (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE S ...